Evidence map›Paper›PMID 31359344›Full record

ReviewObesity surgery2020

The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature.

Shijia Zhang, Sayeed Ikramuddin, Heather C Beckwith, Adam C Sheka, Keith M Wirth, Anne H Blaes

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Obesity surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shijia ZhangDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA.
Sayeed IkramuddinDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA.
Heather C BeckwithDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA.
Adam C ShekaDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA.
Keith M WirthDepartment of Surgery, University of Minnesota, Minneapolis, MN, USA.
Anne H BlaesDivision of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA. blaes004@umn.edu.ORCID 0000-0002-5433-4810
University of Minnesota · US

Funding

Training the Next Generation of Surgeon-Scientists in PancreatologyT32DK108733 · NIDDK · UNIVERSITY OF MINNESOTA · PI Srinath Chinnakotla, MASATO YAMAMOTO · 2017 to 2026
$1.4M
NIDDK NIH HHS T32 DK108733University of Minnesota University of Minnesota Innovation Research Grant
6 · The paper itself

Abstract

backgroundExcess body weight has been associated with worsening breast cancer survival. While bariatric surgery has been associated with less incident of breast cancer, the role that bariatric surgery plays after breast cancer diagnosis in terms of both feasibility and in preventing breast cancer recurrence is unclear.

methodsWe report the outcomes of 13 individuals who underwent bariatric surgery after definitive breast cancer treatment at a single institution.

resultsThirteen females diagnosed with breast cancer (69.2% stage I, 23.1% stage II) at a median age of 42 years received bariatric surgery between 2001 and 2017. The median age of bariatric surgery was 52 years. Of the 13 patients, 46.2% underwent laparoscopic Roux-en-Y gastric bypass and 38.5% laparoscopic sleeve gastrectomy. The median time from breast cancer treatment to bariatric surgery was 3 years. The procedures were well tolerated. One female developed an abdominal wall hematoma. The average weight loss after 1 year and 2 years was 28.1% and 28.2%, respectively. There was a single breast cancer recurrence with a median follow-up of 11.7 years after breast cancer diagnosis and 5.3 years after bariatric surgery.

conclusionsBariatric surgery after breast cancer treatment is feasible and well tolerated. Prospective trials evaluating bariatric surgery in obese breast cancer survivors should be considered.

Indexed as

Bariatric SurgeryAdultBreast NeoplasmsCohort StudiesFemaleGastrectomyGastric BypassHumansLaparoscopyMiddle AgedNeoplasm Recurrence, LocalObesity, MorbidProspective StudiesRetrospective StudiesWeight GainWeight LossBariatric surgeryBreast cancerRecurrenceWeight loss

Identifiers

PMID31359344
PMCPMC9623809
OpenAlexW2966508726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.